Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
BOXER CAPITAL LLC | 08-14-2023 | 06-30-2023 | 79 | 2,156,238,000 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
Reata Pharmaceuticals Inc | CL A | 1 | $145,803,000 | 1,430,004 | 6.76 | 5.49 | 200,000 | 16.26 | 06-30-2023 |
Apellis Pharmaceuticals Inc | COM | 2 | $143,574,000 | 1,576,000 | 6.66 | 5.11 | 0 | 0.00 | 06-30-2023 |
Revolution Medicines Inc | COM | 3 | $125,304,000 | 4,684,264 | 5.81 | 4.98 | 0 | 0.00 | 06-30-2023 |
Tyra Biosciences Inc | COM | 4 | $109,816,000 | 6,448,359 | 5.09 | 5.09 | 0 | 0.00 | 06-30-2023 |